Free Trial

Q2 Earnings Estimate for Diebold Nixdorf Issued By Wedbush

Diebold Nixdorf logo with Computer and Technology background

Diebold Nixdorf, Incorporated (NYSE:DBD - Free Report) - Wedbush issued their Q2 2025 earnings per share (EPS) estimates for shares of Diebold Nixdorf in a report released on Tuesday, July 22nd. Wedbush analyst A. Legault anticipates that the technology company will post earnings of $0.61 per share for the quarter. Wedbush has a "Strong-Buy" rating on the stock. The consensus estimate for Diebold Nixdorf's current full-year earnings is $4.59 per share. Wedbush also issued estimates for Diebold Nixdorf's Q3 2025 earnings at $1.05 EPS, Q4 2025 earnings at $1.54 EPS, FY2025 earnings at $3.57 EPS, Q1 2026 earnings at $1.07 EPS, Q2 2026 earnings at $1.22 EPS, Q3 2026 earnings at $1.52 EPS, Q4 2026 earnings at $1.94 EPS and FY2026 earnings at $5.76 EPS.

Diebold Nixdorf (NYSE:DBD - Get Free Report) last issued its earnings results on Wednesday, May 7th. The technology company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.55 by ($0.48). The firm had revenue of $841.10 million for the quarter, compared to the consensus estimate of $845.95 million. Diebold Nixdorf had a negative net margin of 0.28% and a positive return on equity of 10.20%.

A number of other equities research analysts have also weighed in on the company. Wall Street Zen lowered Diebold Nixdorf from a "buy" rating to a "hold" rating in a research report on Friday, May 9th. CJS Securities raised Diebold Nixdorf to a "strong-buy" rating in a research report on Tuesday, April 1st.

Get Our Latest Analysis on DBD

Diebold Nixdorf Stock Down 0.5%

NYSE DBD traded down $0.31 on Friday, reaching $57.47. 103,172 shares of the stock traded hands, compared to its average volume of 293,702. The company has a debt-to-equity ratio of 0.94, a quick ratio of 0.91 and a current ratio of 1.35. The company has a fifty day moving average price of $53.51 and a 200-day moving average price of $46.95. The company has a market cap of $2.14 billion, a price-to-earnings ratio of -212.85 and a beta of 1.69. Diebold Nixdorf has a 12 month low of $34.38 and a 12 month high of $60.36.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Diebold Nixdorf by 3.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,386 shares of the technology company's stock valued at $619,000 after buying an additional 477 shares in the last quarter. Sterling Capital Management LLC increased its position in Diebold Nixdorf by 821.6% during the 4th quarter. Sterling Capital Management LLC now owns 811 shares of the technology company's stock valued at $35,000 after buying an additional 723 shares in the last quarter. MetLife Investment Management LLC increased its position in Diebold Nixdorf by 5.8% during the 4th quarter. MetLife Investment Management LLC now owns 15,629 shares of the technology company's stock valued at $673,000 after buying an additional 856 shares in the last quarter. Invesco Ltd. increased its position in Diebold Nixdorf by 7.6% during the 4th quarter. Invesco Ltd. now owns 12,297 shares of the technology company's stock valued at $529,000 after buying an additional 867 shares in the last quarter. Finally, CWM LLC increased its position in Diebold Nixdorf by 193.3% during the 2nd quarter. CWM LLC now owns 1,320 shares of the technology company's stock valued at $73,000 after buying an additional 870 shares in the last quarter. 97.04% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Diebold Nixdorf

In related news, EVP Frank Tobias Baur purchased 700 shares of Diebold Nixdorf stock in a transaction dated Friday, May 9th. The stock was purchased at an average cost of $46.12 per share, with a total value of $32,284.00. Following the transaction, the executive vice president owned 38,572 shares in the company, valued at approximately $1,778,940.64. The trade was a 1.85% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.26% of the company's stock.

About Diebold Nixdorf

(Get Free Report)

Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. It operates through two segments, Banking and Retail. The company offers cash recyclers and dispensers, intelligent deposit terminals, teller automation tools, and kiosk technologies, as well as physical security solutions; and front-end applications for consumer connection points and back-end platforms that manage channel transactions, operations and integration, and facilitate omnichannel transactions, endpoint monitoring, remote asset management, customer marketing, merchandise management, and analytics.

Featured Articles

Earnings History and Estimates for Diebold Nixdorf (NYSE:DBD)

Should You Invest $1,000 in Diebold Nixdorf Right Now?

Before you consider Diebold Nixdorf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diebold Nixdorf wasn't on the list.

While Diebold Nixdorf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines